drugset / Trial / NCT00812318
Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the single dose relative bioavailability of GSK1265744 10mg administered in either oral solution fasted, two 5mg tablets fasted, or two 5mg tablets following a moderate meal.
Timeline
- Start
- 2008-06
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cabotegravir | Small molecule | 5 mg | Oral |
| Subject | Cabotegravir | Small molecule | 10 mg | Oral |